1,25-dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin

被引:92
作者
Li, XY [1 ]
Boudjelal, M [1 ]
Xiao, JH [1 ]
Peng, ZH [1 ]
Asuru, A [1 ]
Kang, S [1 ]
Fisher, GJ [1 ]
Voorhees, JJ [1 ]
机构
[1] Univ Michigan, Dept Dermatol, Sch Med, Ann Arbor, MI 48109 USA
关键词
D O I
10.1210/me.13.10.1686
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1,25-Dihydroxyvitamin D-3 (D-3) exerts its effects by binding to and activating nuclear vitamin D-3 receptors (VDRs) that regulate transcription of target genes. We have investigated regulation of VDR levels in human skin in vivo and in cultured human keratinocytes. Quantitative ligand-binding analysis revealed that human skin expressed approximately 220 VDRs per cell, which bound D-3 with high affinity [(dissociation constant (K-d) = 0.22 nM]. In human skin nuclear extracts, VDR exclusively bound to DNA containing vitamin D-3 response elements as heterodimers with retinoid X receptors. Topical application of D-3 to human skin elevated VDR protein levels 2-fold, as measured by both ligand-binding and DNA-binding assays. In contrast, the D-3 analog calcipotriene had no effect on VDR levels. Topical D-3 had no effect on VDR mRNA, indicating that D-3 either stimulated synthesis and/or inhibited degradation of VDRs. To investigate this latter possibility, recombinant VDRs were incubated with skin lysates in the presence or absence of D-3. The presence of D-3 substantially protected VDRs against degradation by human skin lysates. VDR degradation was inhibited by proteasome inhibitors, but not lysosome or serine protease inhibitors. In cultured keratinocytes, D-3 or proteasome inhibitors increased VDR protein without affecting VDR mRNA levels. In cells, VDR was ubiquitinated and this ubiquitination was inhibited by D-3. Proteasome inhibitors in combination with D-3 enhanced VDR-mediated gene expression, as measured by induction of vitamin D-3 24-hydroxylase mRNA in cultured keratinocytes. Taken together, our findings indicate that low VDR levels are maintained, in part, through ubiquitin/proteasome-mediated degradation and that low VDR levels limit D-3 signaling. D-3 exerts dual positive influences on its nuclear receptor, simultaneously stimulating VDR transactivation activity and retarding VDR degradation.
引用
收藏
页码:1686 / 1694
页数:9
相关论文
共 53 条
[1]   Mouse vitamin D-24-hydroxylase: Molecular cloning, tissue distribution, and transcriptional regulation by 1 alpha,25-dihydroxyvitamin D-3 [J].
Akeno, N ;
Saikatsu, S ;
Kawane, T ;
Horiuchi, N .
ENDOCRINOLOGY, 1997, 138 (06) :2233-2240
[2]   STABILIZATION OF THE VITAMIN-D RECEPTOR IN RAT OSTEOSARCOMA CELLS THROUGH THE ACTION OF 1,25-DIHYDROXYVITAMIN-D(3) [J].
ARBOUR, NC ;
PRAHL, JM ;
DELUCA, HF .
MOLECULAR ENDOCRINOLOGY, 1993, 7 (10) :1307-1312
[3]   Induction of 24-hydroxylase cytochrome P450 mRNA by 1,25-dihydroxyvitamin D and phorbol esters in normal rat kidney (NRK-52E) cells [J].
Armbrecht, HJ ;
Chen, ML ;
Hodam, TL ;
Boltz, MA .
JOURNAL OF ENDOCRINOLOGY, 1997, 153 (02) :199-205
[4]   CLONING AND EXPRESSION OF FULL-LENGTH CDNA-ENCODING HUMAN VITAMIN-D RECEPTOR [J].
BAKER, AR ;
MCDONNELL, DP ;
HUGHES, M ;
CRISP, TM ;
MANGELSDORF, DJ ;
HAUSSLER, MR ;
PIKE, JW ;
SHINE, J ;
OMALLEY, BW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (10) :3294-3298
[5]   IMMUNOCYTOCHEMICAL DETECTION OF 1,25-DIHYDROXYVITAMIN-D RECEPTORS IN NORMAL HUMAN-TISSUES [J].
BERGER, U ;
WILSON, P ;
MCCLELLAND, RA ;
COLSTON, K ;
HAUSSLER, MR ;
PIKE, JW ;
COOMBES, RC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (03) :607-613
[6]   REGULATION OF KERATINOCYTE GROWTH, DIFFERENTIATION, AND VITAMIN-D METABOLISM BY ANALOGS OF 1,25-DIHYDROXYVITAMIN-D [J].
BIKLE, DD ;
GEE, E ;
PILLAI, S .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 101 (05) :713-718
[7]   VITAMIN-D, CALCIUM, AND EPIDERMAL DIFFERENTIATION [J].
BIKLE, DD ;
PILLAI, S .
ENDOCRINE REVIEWS, 1993, 14 (01) :3-19
[8]   THE 1,25-DIHYDROXYVITAMIN D-3 (VD) ANALOGS MC903, EB1089 AND KH1060 ACTIVATE THE VD RECEPTOR - HOMODIMERS SHOW HIGHER LIGAND SENSITIVITY THAN HETERODIMERS WITH RETINOID X RECEPTORS [J].
CARLBERG, C ;
MATHIASEN, IS ;
SAURAT, JH ;
BINDERUP, L .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1994, 51 (3-4) :137-142
[9]  
CHEN ML, 1994, P SOC EXP BIOL MED, V207, P57, DOI 10.3181/00379727-207-43791
[10]   THE UBIQUITIN-PROTEASOME PROTEOLYTIC PATHWAY [J].
CIECHANOVER, A .
CELL, 1994, 79 (01) :13-21